FindTrial
Sign In

Secondary infections among Covid 19 patients admitted to ICU

Prevalence and clinical outcomes of secondary infections associated with covid 19 in patients admitted to ICU.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035371
Enrollment
250
Registered
2021-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Sri Ramachandra Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients confirmed positive for COVID 19 disease admitted to the ICU

Exclusion criteria

Exclusion criteria: patients tested negative for COVID 19 disease

Design outcomes

Primary

MeasureTime frame
Prevalence of secondary infection and microbiological speciesTimepoint: after 4 weeks—

Secondary

MeasureTime frame
ICU mortality rate and ICU length of stayTimepoint: After 4weeks—

Countries

India

Contacts

Public ContactDr Baby Sailaja K

Sri Ramachandra Institute of Higher Education and Research

sailajaroop@gmail.com9600159482

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026